Best calming pet products to help soothe your dog, cat's anxiety

From calming beds and lick mats to pheromone diffusers and noise-reducing gear—these pet anxiety products can help during ...
cerebral-overload

Hubble Spies an Active Spiral

A luminous swirl set against the deep black of space, the barred spiral galaxy IC 486 glows with a soft, ethereal light in ...
Discover Magazine

Comet MAPS Breaks Apart Near the Sun, Becoming a Rare Headless Wonder

Learn how Comet C/2026 A1 (MAPS) disintegrated during its close solar pass, forming a “headless wonder,” and what this ...

How NASA's Artemis II mission rediscovered the majesty and mystery of the moon

On April 10, Artemis II—humanity's first mission to the moon in more than half a century—will draw to a close when the Orion ...
ZigWheels

BMW i4 vs Volkswagen Taigun

Compare BMW i4 vs Volkswagen Taigun. Compare prices, specifications, features, and colors of BMW i4 vs Volkswagen Taigun ...
PlanetF1

F1 2026 uncovered: Inside the RB22, SF-26, and W17 technical updates

F1 2026 Uncovered: Inside The RB22, SF-26, And W17 Technical Updates Formula 1’s arrival in Japan represents another ...
TMCnet

Vetology Expands Public AI Validation Dashboard to 11 Metrics Per Classifier, Commits to Ongoing Model Retraining

Vetology's validation data is built on a foundation of 300,000 multi-image patient cases. According to a 2026 Frontiers in Veterinary Science audit, 63.3% of commercial veterinary AI vendors disclose ...
FierceBiotech

Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug

Disc Medicine is laying off a fifth of its workforce as the biotech reels from the FDA’s rejection of its rare blood disease candidate. Last month, the agency knocked back an approval application for ...
The Motley Fool

Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalyst

Disc Medicine develops novel therapeutics targeting hematologic diseases, with a pipeline focused on red blood cell biology, heme biosynthesis, and iron homeostasis. The company operates a ...
Reuters

US FDA declines to approve Disc Medicine's rare disease drug

Feb 13 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Friday the U.S. Food and Drug Administration declined to approve its drug to treat a rare genetic disorder. The drug, bitopertin, was ...
FierceBiotech

FDA rejects Disc's rare disease drug despite commissioner's voucher

The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that had been granted expedited review through a newly launched priority voucher program. While the agency agreed ...